remov
virus
pathogen
microorgan
toxin
import
problem
grow
area
human
therapeut
everi
year
therapeut
product
produc
anim
human
cell
cultur
sourc
sourc
contain
inher
risk
viral
contamin
therapeut
product
human
blood
plasma
antibodi
albumin
factor
viii
name
could
infect
human
immunodefici
viru
hiv
hepat
b
viru
formal
known
parvoviru
sar
coronaviru
one
emerg
virus
yet
identifi
cell
cultur
often
contamin
retroviru
particl
belong
famili
virus
includ
hiv
cell
cultur
line
often
use
product
human
antibodi
may
contain
virus
murin
parvoviru
mvm
cytomegaloviru
contamin
greatli
reduc
sinc
requir
strict
character
cell
cultur
line
care
screen
human
plasma
donor
risk
low
level
contamin
still
exist
fda
requir
process
use
materi
live
sourc
must
two
viral
clearanc
step
lower
risk
contamin
step
must
demonstr
distinct
mechan
viru
clearanc
achiev
minimum
log
remov
two
broad
categori
viral
clearanc
inactiv
remov
inactiv
often
perform
toward
begin
purif
therapeut
could
involv
lower
ph
heat
product
process
work
well
envelop
virus
caution
must
taken
harm
desir
protein
product
viru
remov
often
done
end
process
commonli
involv
nanofiltr
final
product
directli
formul
nanofiltr
work
well
virus
larg
size
howev
small
virus
like
parvovirus
often
approxim
size
protein
product
make
difficult
separ
filtrat
complet
remov
small
nonenvelop
virus
nm
pore
size
filter
accomplish
signific
foul
smallpor
membran
lead
reduct
product
rate
filtrat
parvovirus
improv
floccul
viru
particl
addit
cation
polym
amino
acid
allow
use
larger
pore
membran
foul
quickli
viru
remov
also
accomplish
use
function
membran
surfac
quaternari
amin
group
attach
membran
surfac
facilit
remov
virus
ion
exchang
mechan
viral
clearanc
valid
may
achiev
conduct
spike
experi
normal
process
step
use
purif
therapeut
ie
chromatographi
column
precipit
care
taken
chromatographi
step
use
concurr
viral
clearanc
step
protein
purif
step
viru
protein
bind
resin
possibl
virus
accumul
column
without
proper
clean
viru
may
elut
column
subsequ
batch
contamin
therapeut
product
affin
adsorpt
rare
use
remov
virus
process
stream
common
affin
ligand
virus
antibodi
antibodi
expens
produc
often
withstand
harsh
condit
requir
clean
process
equip
carri
inher
risk
contamin
virus
right
howev
affin
adsorpt
appli
reduct
infecti
prion
blood
small
peptid
ligand
found
remov
staphylococc
enterotoxin
b
small
toxin
e
coli
lysat
small
peptid
robust
antibodi
also
less
expens
chemic
synthes
elimin
risk
viru
contamin
peptid
handl
cycl
product
clean
much
better
antibodi
use
small
peptid
threedimension
structur
may
destroy
process
work
sever
trimer
peptid
discov
remov
ppv
phosphat
buffer
salin
contain
high
human
blood
plasma
peptid
found
synthet
solidphas
combinatori
librari
screen
ligand
bind
porcin
parvoviru
ppv
solidphas
librari
allow
screen
directli
chromatograph
support
use
separ
media
success
discoveri
mani
affin
peptid
ligand
discov
peptid
complet
remov
detect
ppv
pb
complet
remov
detect
ppv
first
column
volum
human
plasma
present
work
demonstr
small
peptid
may
offer
novel
effect
method
remov
virus
complex
mixtur
phosphat
buffer
salin
pb
contain
phosphat
nacl
kcl
ph
purchas
sigma
st
loui
mo
human
blood
plasma
donat
american
red
cross
rockvil
md
amino
acid
phenol
red
sodium
carbon
sodium
phosphat
glucos
calcium
chlorid
sodium
chlorid
potassium
chlorid
magnesium
sulfat
purchas
sigmaaldrich
st
loui
mo
fisher
scientif
waltham
eagl
minimum
essenti
media
emem
purchas
qualiti
biolog
gaithersburg
md
mem
vitamin
steril
pb
trypsin
gentamicin
glutamin
cell
cultur
purchas
invitrogen
carlsbad
ca
porcin
parvoviru
ppv
strain
titrat
propag
porcin
kidney
cell
gift
american
red
cross
rockvil
md
cell
maintain
ppv
propag
describ
heldt
et
al
use
complet
media
consist
emem
supplement
mm
glutamin
gentamicin
nonheatinactiv
fetal
calf
serum
hyclon
logan
ut
upon
propag
viru
cell
cultur
flask
frozen
thaw
room
temperatur
cell
scrape
flask
solut
clarifi
centrifug
rpm
min
iec
centra
centrifug
thermo
electron
waltham
solut
store
use
radioact
ppv
prepar
metabol
incorpor
radiolabel
propag
addit
methionin
cystein
cell
cultur
media
done
seed
cell
cell
per
cm
flask
next
day
flask
infect
mtt
unit
ppv
ml
pb
mtt
unit
defin
concentr
viru
cell
consid
viabl
determin
metabol
cleavag
tetrazolium
bromid
salt
mtt
previous
describ
mtt
concentr
observ
optic
quantifi
spectrophotometri
flask
place
incub
co
humid
h
time
ml
complet
media
ad
flask
return
incub
next
day
media
remov
flask
starvat
media
ad
contain
amino
acid
essenti
nutrient
emem
except
methionin
cell
expos
ml
starvat
media
h
easytag
protein
label
mixtur
perkinelm
waltham
ad
final
concentr
cell
frozen
approxim
cytopath
effect
observ
usual
day
viru
purif
done
cscl
gradient
centrifug
describ
elsewher
solut
dialyz
pb
day
store
use
within
week
infect
measur
made
use
mtt
assay
previous
correl
tcid
tissu
cultur
infecti
dose
common
method
titrat
infecti
virus
solidphas
combinatori
trimer
librari
made
peptid
intern
louisvil
ky
use
dividecouplerecombin
techniqu
toyopearl
amino
ec
tosoh
bioscienc
montgomeryvil
pa
librari
alanin
minipeg
spacer
arm
toyopearl
resinala
coch
och
ch
nh
xxx
x
natur
occur
amino
acid
except
cystein
methionin
librari
swell
methanol
di
water
overnight
buffer
exchang
pb
three
time
last
buffer
exchang
overnight
ten
milligram
dri
librari
taken
mix
human
blood
plasma
pb
h
slabel
ppv
ad
librari
cpm
allow
equilibr
h
librari
place
dispos
ml
frit
column
biorad
laboratori
hercul
ca
bead
wash
pb
follow
pb
contain
addit
nacl
kcl
radioact
could
detect
wash
bead
wash
pb
remov
excess
salt
put
ml
low
melt
agaros
biorad
laboratori
hercul
ca
pour
onto
mm
mm
gelbond
biowhittak
inc
walkersvil
md
allow
dri
day
kodak
biomax
mr
film
kodak
rochest
ny
place
onto
dri
gel
day
develop
konica
medic
film
processor
tokyo
japan
proprietari
ligand
found
american
red
cross
bind
ppv
posit
control
neg
control
amino
use
marker
line
film
gel
visual
radioact
bead
posit
bead
excis
gel
boil
water
min
vortex
water
chang
total
three
repeat
remov
agaros
bound
ppv
bead
bead
sent
texa
protein
laboratori
colleg
station
tx
sequenc
edman
degrad
chromatographi
verifi
screen
result
peptid
resin
synthes
toyopearl
amino
resin
tosoh
bioscienc
montgomeryvil
pa
peptid
intern
louisvil
ky
pack
dispos
piksi
column
promet
bioscienc
ltd
cambridg
england
total
ml
settl
resin
pb
per
column
rainin
oakland
ca
peristalt
pump
use
add
solut
ppv
supernat
either
pb
human
blood
plasma
pb
rate
mlmin
ten
ml
fraction
collect
test
infect
use
mtt
assay
compar
titer
start
materi
addit
column
acetyl
control
made
acetyl
toyopearl
amino
resin
ml
settl
resin
ad
sinter
glass
funnel
allow
drain
resin
wash
three
time
ml
naoh
resin
wash
deioniz
water
ph
resin
place
three
separ
ml
conic
tube
ml
sodium
acet
ad
tube
follow
endoverend
rotat
min
excess
acet
anhydrid
riedeld
haen
germani
amount
total
dissolv
ml
aceton
ml
solut
ad
conic
tube
tube
mix
h
resin
return
sinter
glass
funnel
wash
three
time
ml
di
water
four
time
ml
naoh
final
least
time
ml
di
water
ph
rins
acetyl
confirm
take
acetyl
resin
toyopearl
amino
resin
di
water
ad
two
drop
ninhydrin
reagent
solut
sigma
st
loui
mo
min
resin
observ
color
chang
acetyl
resin
di
water
remain
yellow
wherea
amino
resin
turn
purpl
mani
hexamer
peptid
ligand
found
purifi
protein
toxin
peptid
ligand
select
hexam
librari
contain
million
differ
combin
natur
occur
amino
acid
use
librari
product
would
take
tremend
amount
effort
screen
sequenc
necessari
purif
intend
use
ligand
gener
purif
ligand
use
bind
target
protein
specif
enough
produc
elut
protein
pure
viru
remov
goal
reduct
viru
femtomolar
picomolar
concentr
improv
possibl
find
ligand
accomplish
trimer
librari
design
screen
librari
contain
differ
sequenc
could
screen
mani
time
compar
differ
screen
condit
screen
entir
librari
greater
probabl
one
strongli
bind
ligand
would
found
would
necessarili
occur
hexam
librari
spacer
arm
two
set
two
ethylen
glycol
unit
separ
peptid
bond
design
aeeaaeea
peptid
intern
ad
librari
increas
chanc
find
peptid
ligand
bound
conserv
area
viru
surfac
spacer
arm
separ
peptid
approxim
undisclos
spacer
toyopearl
resin
also
shown
hydrophil
ethylen
glycol
bind
protein
make
flexibl
yet
inert
spacer
arm
allow
movement
ligand
improv
bind
surfac
map
ppv
show
canyon
surfac
viru
approxim
depth
spacer
arm
design
allow
peptid
reach
depth
canyon
nonenvelop
virus
accept
conserv
amino
acid
sequenc
locat
depth
canyon
often
locat
receptor
bind
site
primari
screen
librari
bead
origin
block
human
blood
plasma
viru
ad
block
peptid
high
affin
plasma
protein
addit
ppv
librari
incub
ppv
bead
wash
remov
nonspecif
bound
viru
one
screen
run
wash
nacl
yield
total
posit
bead
anoth
screen
run
wash
kcl
gave
total
posit
bead
posit
bead
larg
signal
size
ratio
ie
small
bead
gave
larg
signal
determin
visual
inspect
chosen
sequenc
result
return
sequenc
shown
tabl
better
determin
signific
differ
chemic
group
amino
acid
count
compar
probabl
random
occurr
tabl
random
occurr
determin
number
amino
acid
chemic
group
divid
number
differ
amino
acid
librari
multipli
total
number
amino
acid
found
sequenc
exampl
five
differ
aliphat
amino
acid
random
number
aliphat
amino
acid
calcul
divid
amino
acid
differ
amino
acid
use
studi
result
multipli
total
amino
acid
trimer
found
screen
give
random
occurr
aliphat
amino
acid
indic
tabl
number
amino
acid
certain
chemic
group
close
random
occurr
number
suspect
chemic
group
randomli
found
may
littl
bind
viru
howev
number
much
higher
expect
occur
randomli
group
consid
signific
bind
viru
tabl
show
import
basic
amino
acid
bind
ppv
complement
lack
acid
group
associ
ligand
found
bind
ppv
result
show
posit
charg
import
bind
viru
expect
result
canin
parvoviru
relat
parvoviru
isoelectr
point
leav
neg
charg
physiolog
ph
correspond
condit
use
screen
studi
random
distribut
aromat
aliphat
group
seven
sequenc
contain
aromat
seven
sequenc
contain
aliphat
sequenc
categor
follow
contain
aromat
amino
acid
contain
aliphat
amino
acid
contain
neither
sinc
one
sequenc
contain
basic
group
sequenc
chosen
screen
contain
basic
amino
acid
categori
five
sequenc
chosen
addit
screen
use
column
chromatographi
wrw
kyy
contain
aromat
raa
contain
aliphat
khr
contain
histidin
also
kkk
krr
combin
form
krk
contain
basic
residu
column
chromatographi
resin
pack
dispos
column
test
breakthrough
ppv
eluent
use
infect
enumer
method
first
cell
cultur
supernat
contain
ppv
dilut
pb
final
titer
log
mttml
approxim
dilut
filter
filter
viru
spike
studi
carri
dilut
concentr
viru
solut
contain
contamin
cell
cultur
creat
may
start
interfer
viru
clearanc
mechan
howev
larger
initi
viral
load
better
opportun
valid
high
degre
viru
clearanc
viru
clearanc
calcul
accord
express
ppv
breakthrough
curv
determin
pump
virusspik
solut
onto
peptid
column
mlmin
fraction
equival
column
volum
collect
total
column
volum
amount
ppv
flowthrough
fraction
determin
result
plot
figur
percentag
detect
ppv
function
column
volum
present
result
term
percentag
detect
clearanc
automat
account
differ
initi
viru
titer
variou
batch
analyz
experi
pb
resin
abl
clear
complet
detect
viru
avail
solut
shown
figur
contrast
amino
resin
control
peptid
consid
weak
ionexchang
resin
abl
remov
signific
amount
ppv
pb
clearli
peptid
respons
bind
viru
nonspecif
bind
resin
surfac
rule
small
peptid
resin
abil
remov
virus
simpl
solut
water
suggest
potenti
applic
water
treatment
fact
microfiltr
consid
altern
chlorin
treatment
water
suppli
method
suffer
mani
difficulti
nanofiltr
therapeut
process
small
virus
like
hepat
viru
diamet
nm
noroviru
diamet
nm
abl
pass
mani
nanofiltr
microfiltr
membran
virus
shed
fece
infect
human
common
contamin
water
suppli
small
peptid
ligand
theoret
could
place
microfiltr
membran
improv
viru
remov
without
need
use
membran
small
pore
size
often
caus
foul
may
requir
high
back
pressur
challeng
peptid
abil
remov
ppv
therapeut
process
condit
virusspik
human
blood
plasma
use
human
blood
plasma
solut
contain
mgml
protein
approxim
amount
protein
found
therapeut
protein
product
two
gener
viral
clearanc
step
monoclon
antibodi
product
process
ie
low
ph
step
cell
harvest
nanofiltr
step
formul
effect
small
peptid
theoret
could
use
membran
nanofiltr
step
end
process
peptid
challeng
protein
load
similar
would
found
phase
purif
process
data
remov
ppv
complex
mixtur
use
peptid
present
figur
resin
test
except
khr
abl
remov
detect
ppv
first
column
volum
resin
breakthrough
ppv
fifth
column
volum
believ
protein
found
human
blood
plasma
also
began
nonspecif
bind
peptid
point
leav
less
peptid
avail
specif
bind
ppv
may
way
improv
select
viru
plasma
protein
optim
chromatographi
process
chang
peptid
densiti
buffer
ionic
strength
amino
control
resin
abil
bind
ppv
remov
solut
first
two
column
volum
pb
human
blood
plasma
amino
control
achiev
log
clearanc
surpris
anion
exchang
column
often
test
abil
clear
virus
shown
qsepharos
column
abl
clear
log
ppv
load
ph
high
log
mvm
load
tri
buffer
ph
follow
trend
increasingli
basic
solut
make
viru
surfac
neg
charg
would
caus
increasingli
stronger
bind
viru
anion
exchang
column
control
experi
weak
ionexchang
resin
ph
show
clearanc
lower
seen
qsepharos
column
would
expect
increas
bind
viru
time
found
amino
control
resin
presenc
absenc
human
blood
plasma
figur
ppv
solut
use
experi
cell
cultur
supernat
clarifi
lowspe
centrifug
filter
filter
solut
contain
cellular
debri
sinc
amino
control
weak
ionexchang
resin
possibl
resin
bind
cellular
debri
viru
bound
debri
resin
mani
protein
host
cell
protein
known
neg
charg
remov
anion
exchang
sinc
amino
resin
high
posit
charg
densiti
also
possibl
cellular
protein
may
denatur
onto
surfac
suspect
ion
exchang
purif
known
happen
protein
adsorb
surfac
protein
denatur
also
log
clearanc
log
viru
detect
clearanc
step
total
viru
load
figur
bind
trimer
peptid
ppv
pb
ligand
abl
bind
detect
ppv
amino
control
weak
ionexchang
resin
abl
clear
less
detect
ppv
column
run
duplic
error
bar
repres
detect
clearanc
column
possibl
observ
purif
tumor
necrosi
factorr
use
ion
exchang
column
longer
host
cell
protein
retain
column
greater
potenti
protein
denatur
may
provid
differ
bind
site
viru
viru
bind
host
cell
protein
confirm
fact
highli
purifi
viru
suspens
contain
less
total
protein
use
resin
challeng
amino
control
resin
bind
log
ppv
even
column
volum
data
shown
virus
also
known
easili
aggreg
presenc
denatur
protein
could
becom
new
bind
surfac
viru
trimer
khr
abl
achiev
log
clearanc
first
column
volum
still
left
solut
log
mttml
viru
peptid
column
show
decreas
viral
clearanc
first
three
column
volum
seen
peptid
resin
subsequ
column
volum
exhibit
increas
detect
clearanc
latter
behavior
seen
amino
control
resin
peptid
resin
suspect
resin
may
caus
denatur
protein
solut
discuss
issu
examin
resin
discard
one
lead
candid
perform
viral
clearanc
ligand
unaccept
trimer
wrw
krk
raa
kyy
exhibit
breakthrough
ppv
presenc
plasma
protein
first
three
column
volum
figur
detect
cooper
bind
observ
resin
flowthrough
fraction
test
resin
wrw
abl
complet
clear
detect
ppv
first
three
column
volum
human
blood
plasma
optim
peptid
densiti
spacer
length
resin
may
abl
clear
ppv
nine
column
volum
challeng
solut
contain
human
blood
plasma
human
blood
plasma
also
contain
mani
differ
protein
one
two
may
interf
bind
ppv
exampl
albumin
predomin
protein
bind
resin
peptid
may
abl
clear
ppv
well
solut
contain
protein
albumin
case
wrw
potenti
use
effect
final
purif
pure
protein
excel
remov
effici
chromatograph
bead
effici
way
remov
larg
particl
process
stream
virus
diamet
order
magnitud
pore
diamet
small
diffus
coeffici
pore
bead
virus
quickli
clog
pore
consequ
access
surfac
area
bead
mainli
associ
outsid
surfac
bead
inner
pore
surfac
avail
bind
membran
better
geometri
bind
particl
virus
diffusion
limit
howev
screen
combinatori
librari
peptid
difficult
membran
surfac
spot
method
develop
ronald
frank
use
produc
peptid
librari
cellulos
membran
surfac
done
manual
sever
hundr
peptid
creat
day
small
librari
compar
thousand
peptid
screen
chromatograph
bead
addit
bind
peptid
cellulos
fiber
may
quit
differ
observ
membran
materi
current
larg
ligand
librari
membran
surfac
like
use
largescal
viru
remov
studi
provid
proofofconcept
peptid
abil
remov
virus
specif
futur
may
benefici
chang
geometri
support
improv
access
ligand
viral
particl
current
bead
geometri
offer
better
screen
platform
small
trimer
ligand
specif
bind
porcin
parvoviru
isol
solidphas
peptid
librari
pb
detect
infecti
viru
remov
solut
everi
fraction
test
nine
column
volum
demonstr
potenti
peptid
use
viru
remov
sampl
rel
simpl
composit
water
purif
applic
complex
mixtur
human
blood
plasma
peptid
wrw
abl
remov
detect
infecti
virus
first
three
column
volum
impress
ligand
contain
three
amino
acid
peptid
ligand
minimum
six
amino
acid
length
enhanc
specif
bind
affin
may
found
use
increas
number
amino
acid
ligand
current
examin
tether
one
ligand
membran
suitabl
geometri
may
improv
viru
remov
effici
complex
mixtur
ligand
could
also
optim
applic
specif
process
stream
singl
ligand
must
compet
one
therapeut
protein
therebi
overcom
competit
bind
facilit
use
effici
viru
absorb
bind
trimer
peptid
ppv
human
blood
plasma
wrw
abl
bind
detect
ppv
first
column
volum
column
volum
wrw
still
abl
bind
much
amino
control
amino
control
acetyl
control
figur
refer
point
comparison
differ
peptid
resin
column
run
duplic
error
bar
repres
detect
clearanc
column
fund
author
also
thank
dr
denni
brown
raquel
hernandez
train
cell
cultur
techniqu
